About
Crown Bioscience is a full-service CRO specializing in translational oncology, offering preclinical and translational research services to accelerate drug discovery and development. They provide a comprehensive suite of solutions including in vivo, in vitro, ex vivo, and in silico methods, advanced laboratory services, and a biobank of biospecimens. Crown Bioscience partners with pharmaceutical and biotech companies to advance therapeutic modalities such as ADCs, cell and gene therapy, and radiopharmaceuticals across various cancer indications.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Crown Bioscience do?
Crown Bioscience is a full-service CRO specializing in translational oncology, offering preclinical and translational research services to accelerate drug discovery and development. They provide a comprehensive suite of solutions including in vivo, in vitro, ex vivo, and in silico methods, advanced laboratory services, and a biobank of biospecimens. Crown Bioscience partners with pharmaceutical and biotech companies to advance therapeutic modalities such as ADCs, cell and gene therapy, and radio…
How much funding has Crown Bioscience raised?
Crown Bioscience has raised a total of $262M in funding. The most recent round on record is Acquisition.
When was Crown Bioscience founded?
Crown Bioscience was founded in 2006.
What is Crown Bioscience's current status?
Crown Bioscience's current operating status is: Acquired.